Effect of Incretin Analogues and Dipeptidyl-peptidase-IV inhibitors on the risk of thyroid cancer

18/10/2023
27/03/2024
EU PAS number:
EUPAS107225
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data source(s), other

Medicare Fee-for-Service (FFS) Database

Data sources (types)

Administrative healthcare records (e.g., claims)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No